Request Free Sample ×
US Esophageal Dysphagia Market Research Report — Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Esophageal Dysphagia Market

ID: MRFR/MED/18384-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

US Esophageal Dysphagia Market Research Report By Diagnosis (Dynamic Swallowing Study, X-ray, Endoscope, Manometry, Imaging scans, MRI scan, CT scan), By Treatment (Esophageal Dilation, Surgery, Stent placement, Laparoscopic Heller Myotomy, Medications, Lifestyle Changes), By Product (Feeding Tube, Nasogastric Tube, Percutaneous Endoscopic Gastrostomy, Nutritional Solutions, Thickeners, Beverages, Purees, Drugs, Proton Pump Inhibitors, Other) and By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Research Centers, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Esophageal Dysphagia Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Life Sciences, BY Diagnosis (USD Million)
  49.     4.1.1 Dynamic Swallowing Study
  50.     4.1.2 X-ray
  51.     4.1.3 Endoscopy
  52.     4.1.4 Manometry
  53.     4.1.5 Imaging scans
  54.     4.1.6 MRI scan
  55.     4.1.7 CT scan
  56.   4.2 Life Sciences, BY Treatment (USD Million)
  57.     4.2.1 Esophageal Dilation
  58.     4.2.2 Surgery
  59.     4.2.3 Stent placement
  60.     4.2.4 Laparoscopic Heller Myotomy
  61.     4.2.5 Medications
  62.     4.2.6 Lifestyle Changes
  63.   4.3 Life Sciences, BY Product (USD Million)
  64.     4.3.1 Feeding Tubes
  65.     4.3.2 Nasogastric Tubes
  66.     4.3.3 Percutaneous Endoscopic Gastrostomy
  67.     4.3.4 Nutritional Solutions
  68.     4.3.5 Thickeners
  69.     4.3.6 Beverages
  70.     4.3.7 Purees
  71.     4.3.8 Drugs
  72.     4.3.9 Proton Pump Inhibitors
  73.     4.3.10 Others
  74.   4.4 Life Sciences, BY End-User (USD Million)
  75.     4.4.1 Hospitals and Clinics
  76.     4.4.2 Ambulatory Surgical Centers
  77.     4.4.3 Diagnostic Centers
  78.     4.4.4 Research Centers
  79.     4.4.5 Others
  80. 5 SECTION V: COMPETITIVE ANALYSIS
  81.   5.1 Competitive Landscape
  82.     5.1.1 Overview
  83.     5.1.2 Competitive Analysis
  84.     5.1.3 Market share Analysis
  85.     5.1.4 Major Growth Strategy in the Life Sciences
  86.     5.1.5 Competitive Benchmarking
  87.     5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  88.     5.1.7 Key developments and growth strategies
  89.       5.1.7.1 New Product Launch/Service Deployment
  90.       5.1.7.2 Merger & Acquisitions
  91.       5.1.7.3 Joint Ventures
  92.     5.1.8 Major Players Financial Matrix
  93.       5.1.8.1 Sales and Operating Income
  94.       5.1.8.2 Major Players R&D Expenditure. 2023
  95.   5.2 Company Profiles
  96.     5.2.1 Medtronic (US)
  97.       5.2.1.1 Financial Overview
  98.       5.2.1.2 Products Offered
  99.       5.2.1.3 Key Developments
  100.       5.2.1.4 SWOT Analysis
  101.       5.2.1.5 Key Strategies
  102.     5.2.2 Boston Scientific (US)
  103.       5.2.2.1 Financial Overview
  104.       5.2.2.2 Products Offered
  105.       5.2.2.3 Key Developments
  106.       5.2.2.4 SWOT Analysis
  107.       5.2.2.5 Key Strategies
  108.     5.2.3 Johnson & Johnson (US)
  109.       5.2.3.1 Financial Overview
  110.       5.2.3.2 Products Offered
  111.       5.2.3.3 Key Developments
  112.       5.2.3.4 SWOT Analysis
  113.       5.2.3.5 Key Strategies
  114.     5.2.4 Abbott Laboratories (US)
  115.       5.2.4.1 Financial Overview
  116.       5.2.4.2 Products Offered
  117.       5.2.4.3 Key Developments
  118.       5.2.4.4 SWOT Analysis
  119.       5.2.4.5 Key Strategies
  120.     5.2.5 Cook Medical (US)
  121.       5.2.5.1 Financial Overview
  122.       5.2.5.2 Products Offered
  123.       5.2.5.3 Key Developments
  124.       5.2.5.4 SWOT Analysis
  125.       5.2.5.5 Key Strategies
  126.     5.2.6 Olympus Corporation (JP)
  127.       5.2.6.1 Financial Overview
  128.       5.2.6.2 Products Offered
  129.       5.2.6.3 Key Developments
  130.       5.2.6.4 SWOT Analysis
  131.       5.2.6.5 Key Strategies
  132.     5.2.7 Conmed Corporation (US)
  133.       5.2.7.1 Financial Overview
  134.       5.2.7.2 Products Offered
  135.       5.2.7.3 Key Developments
  136.       5.2.7.4 SWOT Analysis
  137.       5.2.7.5 Key Strategies
  138.     5.2.8 Stryker Corporation (US)
  139.       5.2.8.1 Financial Overview
  140.       5.2.8.2 Products Offered
  141.       5.2.8.3 Key Developments
  142.       5.2.8.4 SWOT Analysis
  143.       5.2.8.5 Key Strategies
  144.     5.2.9 B. Braun Melsungen AG (DE)
  145.       5.2.9.1 Financial Overview
  146.       5.2.9.2 Products Offered
  147.       5.2.9.3 Key Developments
  148.       5.2.9.4 SWOT Analysis
  149.       5.2.9.5 Key Strategies
  150.   5.3 Appendix
  151.     5.3.1 References
  152.     5.3.2 Related Reports
  153. 6 LIST OF FIGURES
  154.   6.1 MARKET SYNOPSIS
  155.   6.2 US MARKET ANALYSIS BY DIAGNOSIS
  156.   6.3 US MARKET ANALYSIS BY TREATMENT
  157.   6.4 US MARKET ANALYSIS BY PRODUCT
  158.   6.5 US MARKET ANALYSIS BY END-USER
  159.   6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
  160.   6.7 RESEARCH PROCESS OF MRFR
  161.   6.8 DRO ANALYSIS OF LIFE SCIENCES
  162.   6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
  163.   6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
  164.   6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
  165.   6.12 LIFE SCIENCES, BY DIAGNOSIS, 2024 (% SHARE)
  166.   6.13 LIFE SCIENCES, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
  167.   6.14 LIFE SCIENCES, BY TREATMENT, 2024 (% SHARE)
  168.   6.15 LIFE SCIENCES, BY TREATMENT, 2024 TO 2035 (USD Million)
  169.   6.16 LIFE SCIENCES, BY PRODUCT, 2024 (% SHARE)
  170.   6.17 LIFE SCIENCES, BY PRODUCT, 2024 TO 2035 (USD Million)
  171.   6.18 LIFE SCIENCES, BY END-USER, 2024 (% SHARE)
  172.   6.19 LIFE SCIENCES, BY END-USER, 2024 TO 2035 (USD Million)
  173.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  174. 7 LIST OF TABLES
  175.   7.1 LIST OF ASSUMPTIONS
  176.     7.1.1
  177.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  178.     7.2.1 BY DIAGNOSIS, 2025-2035 (USD Million)
  179.     7.2.2 BY TREATMENT, 2025-2035 (USD Million)
  180.     7.2.3 BY PRODUCT, 2025-2035 (USD Million)
  181.     7.2.4 BY END-USER, 2025-2035 (USD Million)
  182.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  183.     7.3.1
  184.   7.4 ACQUISITION/PARTNERSHIP
  185.     7.4.1

US Life Sciences Market Segmentation

Life Sciences By Diagnosis (USD Million, 2025-2035)

  • Dynamic Swallowing Study
  • X-ray
  • Endoscopy
  • Manometry
  • Imaging scans
  • MRI scan
  • CT scan

Life Sciences By Treatment (USD Million, 2025-2035)

  • Esophageal Dilation
  • Surgery
  • Stent placement
  • Laparoscopic Heller Myotomy
  • Medications
  • Lifestyle Changes

Life Sciences By Product (USD Million, 2025-2035)

  • Feeding Tubes
  • Nasogastric Tubes
  • Percutaneous Endoscopic Gastrostomy
  • Nutritional Solutions
  • Thickeners
  • Beverages
  • Purees
  • Drugs
  • Proton Pump Inhibitors
  • Others

Life Sciences By End-User (USD Million, 2025-2035)

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Research Centers
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓